Sponsor Dossier
Vertex Pharmaceuticals
Sponsor Dossier for Vertex Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Vertex Pharmaceuticals is an Australian Private Company with ABN 34 160 157 157, registered in NSW and currently active.
Portfolio
Vertex Pharmaceuticals has 5 brands on the ARTG, of which 5 are indexable and 5 carry a Product Information document. 5 brands are PBS-listed, 5 have a PBAC outcome on record, and 5 have an AusPAR on record. Notable brands include ALYFTREK, KALYDECO, ORKAMBI, SYMDEKO, TRIKAFTA.
Therapeutic focus
— Rare Disease: 5 brands
PBS footprint
5 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 5 brands with a PBAC outcome on record. The latest AusPAR is 2026-04-29, across 5 brands with an AusPAR on record.